FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.06-7464revv1
21/4/968    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, L. H. K.
Right arrow Articles by Pervaiz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, L. H. K.
Right arrow Articles by Pervaiz, S.
Published online before print January 10, 2007 as doi: 10.1096/fj.06-7464rev.

Annexin 1: the new face of an old molecule

Lina H. K. Lim and Shazib Pervaiz

E-mail contact: phssp@ nus.edu.sg

The annexin superfamily consists of 13 calcium or calcium and phospholipid binding proteins with a significant degree of biological and structural homology (40-60%). First described in the late 1970s and subsequently referred to as macrocortin, renocortin, lipomodulin, lipocortin-1, and more recently Annexin 1, this 37 kDa calcium and phospholipid binding protein is a strong inhibitor of glucocorticoid-induced eicosanoid synthesis and PLA2. Recent interest in the biological activity of this intriguing molecule has unraveled important functional attributes of Annexin 1 in a variety of inflammatory pathways, on cell proliferation machinery, in the regulation of cell death signaling, in phagocytic clearance of apoptosing cells, and most importantly in the process of carcinogenesis. Here we attempt to present a short review on these diverse biological activities of an interesting and important molecule, which could be a potential target for novel therapeutic intervention in a host of disease states.-- Lim, L. H. K., Pervaiz, S. Annexin 1: the new face of an old molecule.




This article has been cited by other articles:


Home page
 IOVSHome page
M. Menegay, D. Lee, K. F. Tabbara, T. A. Cafaro, J. A. Urrets-Zavalia, H. M. Serra, and S. K. Bhattacharya
Proteomic Analysis of Climatic Keratopathy Droplets
Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 2829 - 2837.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium
Hypertension, April 1, 2008; 51(4): 915 - 921.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Sakaguchi, H. Murata, H. Sonegawa, Y. Sakaguchi, J.-i. Futami, M. Kitazoe, H. Yamada, and N.-h. Huh
Truncation of Annexin A1 Is a Regulatory Lever for Linking Epidermal Growth Factor Signaling with Cytosolic Phospholipase A2 in Normal and Malignant Squamous Epithelial Cells
J. Biol. Chem., December 7, 2007; 282(49): 35679 - 35686.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. P. Herbert, A. F. Odell, S. Ponnambalam, and J. H. Walker
The Confluence-dependent Interaction of Cytosolic Phospholipase A2-{alpha} with Annexin A1 Regulates Endothelial Cell Prostaglandin E2 Generation
J. Biol. Chem., November 23, 2007; 282(47): 34468 - 34478.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by The Federation of American Societies for Experimental Biology.